Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma

Clinical Trial ID NCT00679289

Rank	Title	Journal	Year	PubWeight™‹?›
1	Adjuvant therapy for melanoma.	Cancer J	2012	1.01
2	Cancer cell associated glycans as targets for immunotherapy.	Oncoimmunology	2015	0.75